Myriad Genetics
MYGN
#6699
Rank
S$0.85 B
Marketcap
S$9.19
Share price
-3.27%
Change (1 day)
-58.03%
Change (1 year)

Myriad Genetics (MYGN) - Cash on Hand

Cash on Hand as of September 2025 : S$0.18 Billion

According to Myriad Genetics's latest financial reports the company has S$0.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Myriad Genetics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.13 B-25.2%
2023-12-31S$0.18 B20.81%
2022-12-31S$0.15 B-66.37%
2021-12-31S$0.45 B
2020-06-30S$0.30 B64.02%
2019-06-30S$0.18 B-24.81%
2018-06-30S$0.24 B18.65%
2017-06-30S$0.20 B-3.15%
2016-06-30S$0.21 B9.79%
2015-06-30S$0.19 B-16.04%
2014-06-30S$0.23 B-50.81%
2013-06-30S$0.47 B9.5%
2012-06-30S$0.43 B1.49%
2011-06-30S$0.42 B-24.07%
2010-06-30S$0.55 B22.33%
2009-06-30S$0.45 B2.31%
2008-06-30S$0.44 B36.21%
2007-06-30S$0.32 B-9.39%
2006-06-30S$0.36 B88.05%
2005-06-30S$0.19 B-2.53%
2004-06-30S$0.19 B54.77%
2003-06-30S$0.12 B-1.07%
2002-06-30S$0.12 B-44.3%
2001-06-30S$0.23 B66.55%
2000-06-30S$0.13 B725.83%
1999-06-30S$16.85 M-31.44%
1998-06-30S$24.58 M9.5%
1997-06-30S$22.45 M20.52%
1996-06-30S$18.63 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bio-Rad Laboratories
BIO
S$1.83 B 875.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
S$1.30 B 589.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
S$8.59 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.91 B 916.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.02 B 5,218.43%๐Ÿ‡บ๐Ÿ‡ธ USA